• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Pfizer CEO Albert Bourla
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By Matthew Perrone and The Associated PressNovember 16, 2021
FDA authorizes COVID vaccine for kids ages 5 to 11
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 29, 2021
Vaccines for kids
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 26, 2021
Moderna vaccine
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 20, 2021
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 14, 2021
FDA will not make a decision on Merck’s COVID antiviral pill until December
Health
FDA will not make a decision on Merck’s COVID antiviral pill until December
By Matthew Perrone and The Associated PressOctober 14, 2021
FDA debates timeline for administering Johnson & Johnson booster shots
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 13, 2021
FDA panel will advise on Johnson & Johnson booster shots this week
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By Matthew Perrone and The Associated PressOctober 1, 2021
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By Matthew Perrone, Lauran Neergaard, Mike Stobbe and The Associated PressSeptember 22, 2021
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
Health
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By Matthew Perrone, Lauran Neergaard and The Associated PressSeptember 17, 2021
FDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
Health
FDA strikes neutral tone ahead of Friday’s COVID vaccine booster meeting
By Lauran Neergaard, Matthew Perrone and The Associated PressSeptember 15, 2021
FDA delays decision on whether Juul can remain on the market
Health
FDA delays decision on whether Juul can remain on the market
By Matthew Perrone and The Associated PressSeptember 9, 2021
Pfizer COVID-19 vaccine gets full approval from U.S. FDA
Health
Pfizer COVID-19 vaccine gets full approval from U.S. FDA
By Lauran Neergaard, Matthew Perrone and The Associated PressAugust 23, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
Middle East
The emerging deal to reopen the Strait of Hormuz reportedly recognizes Iran’s control—and the U.S. may have to accept itplaceholder alt text
By Jason MaAugust 7, 2026
Environment
Leo DiCaprio teams with Jeff and Lauren Sanchez Bezos on $200 million plan to save 100 endangered speciesplaceholder alt text
By The Associated PressAugust 5, 2026
Economy
The deportation economy is backfiring on American workers, top economist warnsplaceholder alt text
By Eva RoytburgAugust 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.